Pharmaceutical Lifecycle Management Training


Pharmaceutical Lifecycle Management Training: Making the Most of Each and Every Brand

The global research-based pharmaceutical industry lies increasingly between the “rock” of empty pipelines and the “hard place” of cost containment and more aggressive generic competition. In this environment it is essential to exploit the whole spectrum of available lifecycle management (LCM) options to maximize the performance of existing brand assets.

EBCG’s Pharmaceutical Lifecycle Management Course strives to critically assess all of these options, looking at past, concrete examples that have been successful – and those that have been unsuccessful - and evaluating those that will continue to be sustainable going forward. At the end of the two days, attendees will be ready to go back to their companies to re-evaluate and optimize the lifecycle plans of their marketed products and developmental projects.

DAY 1 looks at the overall environment in which lifecycle management strategies must deliver, and then examines in detail each of the technical components in the management of an overall lifecycle: regulatory and legal aspects; patents and other exclusivities; indication expansion and sequencing; reformulation, new routes of administration and drug delivery; fixed-dose combinations; modified chemistries, and much more. Day 1 will also look at how to turn various options into robust winning strategies, as well as describe a proven process for creating an actual LCM Plan, and provide tips on how to ensure that senior management buys into that plan.

DAY 2 switches from the more technical side of LCM to look at commercial options for optimizing brand performance over the whole lifecycle. It will cover areas like geographical expansion and optimization, OTC switching, brand loyalty and service programs, strategic pricing strategies, the value of LCM projects in the overall R&D portfolio and the management of mature (post-patent) product portfolios. Day 2 also will consider all of the options for brand companies to compete or collaborate with the generic drug industry – including acquisition, the creation of an in-house generics unit, settlements, authorized generics, API supply agreements, private labeling, and so on.

• An understanding of all of the regulatory, scientific and technical options for optimizing the brand life cycle
• A process for selecting the best options to create an integrated, brand-specific LCM Plan which describes a sustainable strategy for maximizing the performance of a brand over its whole life cycle
• Practical tips on how to ensure that senior management buys into the LCM Plan (i.e. supports it AND provides the resources required to make it happen!)

• An understanding of all of the commercial options (strategic and tactical) for optimizing the brand life cycle
• Alternative strategies for dealing with generic competition late in the brand life cycle
• How to create and manage a portfolio of mature (post-patent) brands

Quote 'SLCTT' for SelectScience membership discount!!

5* Hotel in the center of the city

Organizer: European Business Conferences Group

16 Sep 2013

Neuroscience 201415 Nov 2014 Read
ASCB 20146 Dec 2014 Read
SLAS20157 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read
ESCMID European Society of Clinical Microbiology and Infectious Diseases25 Apr 2015 Read
AACC (American Association for Clinical Chemistry)26 Jul 2015 Read
Neuroscience 201517 Oct 2015 Read

1 2 Next 
Clinical Trial Supply East Coast 201428 Oct 2014 Read
AAPS Annual Meeting and Exposition2 Nov 2014 Read
International Ion Channel Retreat 20145 Nov 2014 Read
European Antibody Congress 201410 Nov 2014 Read
World Biosimilar Congress 201411 Nov 2014 Read
Clinical Trials in CNS11 Nov 2014 Read
Advances in Cell Based Assays11 Nov 2014 Read
World Orphan Drug Congress Europe 201412 Nov 2014 Read
Medica 201412 Nov 2014 Read
HPAPI World Congress 201412 Nov 2014 Read
Neuroscience 201415 Nov 2014 Read
3rd Annual Cell Culture and Bioprocessing Congress 201417 Nov 2014 Read
Translating Innovations in Diabetes Drug Development17 Nov 2014 Read
6th Annual Next Generation Sequencing Congress 201420 Nov 2014 Read
2nd Annual Single Cell Analysis Congress 201420 Nov 2014 Read
Pharmacovigilance, Drug Safety and Risk Management 201426 Nov 2014 Read
9th Annual Cold Chain Distribution Conference and Exhibition2 Dec 2014 Read
ASCB 20146 Dec 2014 Read
Pharmaceutical Microbiology21 Jan 2015 Read
MedLab26 Jan 2015 Read
7th Annual Pre-Filled Syringes Conference and Exhibition28 Jan 2015 Read
Biophysical Society 59th Annual Meeting7 Feb 2015 Read
SLAS20157 Feb 2015 Read
Advances and Progress in Drug Design 201516 Feb 2015 Read
RNA Therapeutics16 Feb 2015 Read
Cell Culture World Congress24 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
ACS National Meeting and Exposition22 Mar 2015 Read
Arablab23 Mar 2015 Read
Experimental Biology28 Mar 2015 Read